Stockreport

Inozyme Pharma to Participate in the TD Cowen 44th Annual Health Care Conference

Inozyme Pharma, Inc.  (INZY) 
PDF BOSTON, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company develop [Read more]